1.Age‑related changes in hematological and biochemical profiles of Wistar rats
Suresh PATEL ; Satish PATEL ; Ashvin KOTADIYA ; Samir PATEL ; Bhavesh SHRIMALI ; Nikita JOSHI ; Tushar PATEL ; Harshida TRIVEDI ; Jitendra PATEL ; Amit JOHARAPURKAR ; Mukul JAIN
Laboratory Animal Research 2024;40(1):84-95
Background:
Wistar rats are extensively used as the model for assessing toxicity and efficacy in preclinical research.Hematological and biochemical laboratory data are essential for evaluating specific variations in the physiological and functional profile of a laboratory animal. Establishing hematological and biochemical reference values for Wistar (han) rats at various age intervals was the goal of this work. Male and female Wistar rats (n = 660) of ages 6–8 weeks, 10–14 weeks and > 6 months were used in the experiment. Blood and serum were collected from these rats under fasting conditions.
Results:
We observed that the majority of hematological and biochemical parameters were significantly influenced by sex and age. Hematological changes were significantly correlated to aging were increased red blood cells, hemoglobin, hematocrit, neutrophils, monocytes and eosinophils in both sexes, as well as decreased platelet, mean corpuscular volume, mean corpuscular hemoglobin and lymphocytes in both sexes. White blood cells of male rats were considerably higher than those of female rats in all age ranges. For biochemistry, increase in glucose, total protein and creatinine were seen in both sexes, along with increases in urea in females and alanine aminotransferase in males.Age was significantly associated with decreased alkaline phosphatase in both sexes.
Conclusions
When using Wistar rats as a model, these reference values may be useful in evaluating the results.
2.Lumbar Spinal Steroid Injections and Infection Risk after Spinal Surgery: A Systematic Review and Meta-Analysis
Harshadkumar A. PATEL ; Naga Suresh CHEPPALLI ; Amit Wasudeo BHANDARKAR ; Vidhi PATEL ; Anuj SINGLA
Asian Spine Journal 2022;16(6):947-957
Lumbar spinal steroid injections (LSSI) are universally used as preferred diagnostic or therapeutic treatment options before major spinal surgeries. Some recent studies have reported higher risks of surgical-site infection (SSI) for spinal surgeries performed after injections, while others have overlooked such associations. The purpose of this study is to systematically review the literature and perform a meta-analysis to evaluate the associations between preoperative LSSI and postoperative infection following subsequent lumbar decompression and fusion procedures. Three databases, namely PubMed, Scopus, and Cochrane Library, were searched for relevant studies that reported the association of spinal surgery SSI with spinal injections. After the comprehensive sequential screening of the titles, abstracts, and full articles, nine studies were included in a systematic review, and eight studies were included in the meta-analysis. Studies were critically appraised for bias using the validated MINOR (methodological index for non-randomized studies) score. The odds ratio (OR) and 95% confidence interval (CI) were calculated. Subgroup analysis was performed according to the time between LSSI and surgery and the type of lumbar spine surgery. Meta-analysis showed that preoperative LSSI within 30 days of lumbar spine surgery was associated with significantly higher postoperative infection compared with the control group (OR,1.79; 95% CI, 1.08–2.96). Based on subgroup analysis, lumbar spine fusion surgery within 30 days of preoperative LSSI was associated with significantly high-infection rates (OR, 2.67; 95% CI, 2.12–3.35), while no association was found between preoperative LSSI and postoperative infection for lumbar spine decompression surgeries. In summary, given the absence of high-level studies in the literature, careful clinical interpretation of the results should be performed. The overall risk of SSI was slightly higher if the spinal surgery was performed within 30 days after LSSIs. The risk was higher for lumbar fusion cases but not for decompression-only procedures.
3.Predicting recurrence in oral cavity cancers: a review of 116 patients with buccal mucosa carcinoma in northwestern India
Pinakin PATEL ; Pranav Mohan SINGHAL ; Kamal Kishor LAKHERA ; Aishwarya CHATTERJEE ; Agil BABU ; Suresh SINGH ; Shubhra SHARMA ; Bhoopendra Singh GORA ; Naina Kumar AGARWAL
Archives of Craniofacial Surgery 2023;24(5):211-217
Background:
Oral cavity cancers, the second most common type in India, are responsible for 10% of the overall cancer burden. With a recurrence rate of 30% to 40% and a 5-year survival rate of 50%, these malignancies account for substantial morbidity and mortality. Despite advances in treatment modalities, survival rates following treatment completion have not improved significantly. The present study aimed to establish specific epidemiological and pathological factors responsible for recurrence after treatment completion in buccal mucosa cancers.
Methods:
A retrospective analysis of the data of 116 patients treated for biopsy-proven cancers of the buccal mucosa was undertaken 1 year after treatment completion. Factors such as age, sex, education, lymphovascular invasion, extranodal extension (ENE), perineural invasion, depth of invasion, and pathological margin status were compared between patients who presented with recurrence and those who did not. Statistical significance was set at p< 0.05.
Results:
Of the 116 patients, 40 (34.5%) developed a recurrent disease within 1 year. The mean age of the study population was 43.3 years, and males constituted 91.4% of the included patients. Ipsilateral buccal mucosa was the commonest site of disease recurrence. Neck node metastasis, ENE, and margins of resection < 5 mm were significantly related to the recurrence of disease. However, surprisingly, lymphovascular invasion, perineural invasion, and depth of invasion > 10 mm did not show statistically significant associations.
Conclusion
Neck node metastasis, ENE, and margins of resection < 5 mm were the histopathological factors associated with recurrence in cancers of the buccal mucosa.
4.A Phantom-based Investigation Into the Influence of Low Tube Potential and Matrix Size on Radiation Dose and Image Quality for a 128 Slice Abdominopelvic Ct Protocol
Nitika C. Panakkal ; Rajagopal Kadavigere ; Suresh Sukumar ; Ravishankar N
Malaysian Journal of Medicine and Health Sciences 2022;18(No.2):14-19
Introduction: Reducing radiation dose for CT examinations has been accompanied by an increase in image noise.
Studies have highlighted the application of a higher matrix size for improving image quality when assessing the
lungs. This study aims to evaluate the influence of a low kVp and higher matrix size on radiation dose and image
quality for abdominopelvic CT. Methods: This experiment was done on a 32 cm body phantom and scanned using a
128 slice CT scanner. The study utilised various combinations of kVp settings (140, 120, 100, 80 & 70) and matrix
sizes (1024, 768 & 512). The image obtained was analysed objectively and subjectively. For objective analysis, we
calculated SNR, and CNR. For subjective analysis, two radiologists evaluated the image in a 3-point scoring scale.
Results: The study reported an increase in SNR (0.8%) and CNR (46%) at 120 kVp when increasing the matrix size
from 512 x 512 to 768 x 768. Similarly, there was an increase of 14.5 % and 56.4 % in CNR and SNR using 1024
matrix size. The DLP was reduced by 4.5%, 50% and 70.6 % using 100, 80 and 70 kVp respectively. However,
there was no change in DLP with higher matrix sizes. Conclusion: The study reported a combination of 100 kVp and
768 matrix size resulted in an almost similar (↓0.9 %) SNR and improved CNR (↑46.4 %) compared to 120 kVp and
512 matrix size. Qualitative analysis also showed a similar image quality with decreased radiation dose for abdominopelvic CT.
5.Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Nitin Bharat CHARBE ; Nikhil D AMNERKAR ; B RAMESH ; Murtaza M TAMBUWALA ; Hamid A BAKSHI ; Alaa A A ALJABALI ; Saurabh C KHADSE ; Rajendran SATHEESHKUMAR ; Saurabh SATIJA ; Meenu METHA ; Dinesh Kumar CHELLAPPAN ; Garima SHRIVASTAVA ; Gaurav GUPTA ; Poonam NEGI ; Kamal DUA ; Flavia C ZACCONI
Acta Pharmaceutica Sinica B 2020;10(11):2075-2109
In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool to deliver DNA-based products to cancer cells. This review aims to highlight the latest development in the lipids and polymeric nanocarrier for siRNA delivery to the cancer cells. It also provides the necessary information about siRNA development and its mechanism of action. Overall, this review gives us a clear picture of lipid and polymer-based drug delivery systems, which in the future could form the base to translate the basic siRNA biology into siRNA-based cancer therapies.